Diagnosis codes were identified across a number of potential services including inpatient/outpatient, specialty care, and pharmacotherapy prescriptions
The advancement of incretin-based therapeutics has resulted in a sea change in the management of type 2 diabetes, with the most recently developed agents promoting notable reductions in weight as well 6,7,8
Most of that loss occurs during the first 40 weeks, with the rate being highest between weeks 8 and 24 of therapeutic dosing
Cardiovascular outcomes data from TRIUMPH-Outcomes is long-term and would not gate the initial obesity approval, though it would shape any later cardiovascular indication
From our 2-minute eligibility quiz to asynchronous doctor consultations, weve built a streamlined experience that doesnt require patients to jump through hoops
Compounded semaglutide side effects Compounded semaglutide versions are expected to have similar side effects to Ozempic and Wegovy, with some additional risks